Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Mazdutide for Treating PCOS
Sponsor: Shanghai Zhongshan Hospital
Summary
The goal of this clinical trial is to learn the efficacy of Mazdutide in treating obese female adults diagnosed with polycystic ovary syndrome (PCOS). The main question it aims to answer is: Does Mazdutide lower the free androgen index (FAI) in obese female adults with PCOS? Participants will take Mazdutide once every week for 24 weeks and visit the clinic once every 4 weeks for checkups and tests.
Official title: A Clinical Efficacy Study of Mazdutide in the Treatment of Polycystic Ovary Syndrome
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-10-21
Completion Date
2026-06-30
Last Updated
2024-10-24
Healthy Volunteers
No
Conditions
Interventions
Mazdutide
In the initial 4 weeks, the subjects are given Mazdutide 2mg once weekly. If well tolerated, the dosage is increased to 4mg once weekly for another 4 weeks. If still well tolerated, the dosage is further increased to 6mg once weekly and maintained for the ensuing 16 weeks.
Locations (1)
Zhongshan Hospital Fudan University
Shanghai, China